Joshua T. Ayers

发表

N,N′-Alkane-diyl-bis-3-picoliniums as Nicotinic Receptor Antagonists: Inhibition of Nicotine-Evoked Dopamine Release and Hyperactivity

L. Dwoskin, P. Crooks, M. Bardo, 2008, Journal of Pharmacology and Experimental Therapeutics.

N , N (cid:1) -Alkane-diyl- bis -3-picoliniums as Nicotinic Receptor Antagonists: Inhibition of Nicotine-Evoked Dopamine Release and Hyperactivity

L. Dwoskin, M. Bardo, V. Manda, 2008 .

Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.

L. Dwoskin, P. Crooks, A. Deaciuc, 2004, Bioorganic & medicinal chemistry letters.

N-n-Alkylpyridinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Selective Inhibition of Nicotine-Evoked [3H]Dopamine Overflow from Superfused Rat Striatal Slices

L. Dwoskin, P. Crooks, Aaron J Haubner, 2003, Journal of Pharmacology and Experimental Therapeutics.

N-n-Alkylnicotinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Interaction with α4β2* and α7* Neuronal Nicotinic Receptors

L. Dwoskin, P. Crooks, J. T. Ayers, 2003, Journal of Pharmacology and Experimental Therapeutics.

N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.

L. Dwoskin, P. Crooks, Aaron J Haubner, 2002 .

N-n-Alkylpyridinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Selective Inhibition of Nicotine-Evoked [3H]Dopamine Overflow from Superfused Rat Striatal Slices

L. Dwoskin, P. Crooks, Aaron J Haubner, 2003, Journal of Pharmacology and Experimental Therapeutics.

Recent developments in neuronal nicotinic acetylcholine receptor antagonists

L. Dwoskin, P. Crooks, J. T. Ayers, 2000 .

N-n -Alkylnicotinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Interaction with (cid:1) 4 (cid:2) 2* and (cid:1) 7* Neuronal Nicotinic Receptors

L. Dwoskin, P. Crooks, J. T. Ayers, 2002 .

N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S(-)-nicotine-evoked [(3)H]dopamine overflow from superfused rat striatal slices.

L. Dwoskin, Aaron J Haubner, Peter A. Crooks, 2002, The Journal of pharmacology and experimental therapeutics.

N - n -Alkylnicotinium Analogs, A Novel Class of Nicotinic Receptor Antagonist: Inhibition of S ( (cid:1) )-Nicotine-Evoked [ 3 H]Dopamine Overflow from Superfused Rat Striatal Slices

L. Dwoskin, Aaron J Haubner, Peter A. Crooks, 2002 .

N-n -Alkylnicotinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Interaction with (cid:1) 4 (cid:2) 2* and (cid:1) 7* Neuronal Nicotinic Receptors

L. Dwoskin, V. Grinevich, Peter A. Crooks, 2002 .

Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the α4β2 nicotinic acetylcholine receptor subtype using nonlinear techniques

A. Clauset, L. Dwoskin, P. Crooks, 2005, The AAPS Journal.

N‐n‐alkylnicotinium and N‐n‐alkylpyridinium analogs inhibit the dopamine transporter: Selectivity as nicotinic receptor antagonists

L. Dwoskin, P. Crooks, P. Crooks, 2003 .

bis-azaaromatic quaternary ammonium analogues: Ligands for α4β2* and α7* subtypes of neuronal nicotinic receptors

L. Dwoskin, P. Crooks, A. Deaciuc, 2002 .

Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.

L. Dwoskin, P. Crooks, A. Deaciuc, 2004, Bioorganic & medicinal chemistry letters.

N-n-alkylnicotinium analogs, a novel class of antagonists at α4β2* Nicotinic acetylcholine receptors: Inhibition of S(-)-nicotine-evoked 86Rb+Efflux from rat thalamic synaptosomes

L. Dwoskin, P. Crooks, Dennis K. Miller, 2005, The AAPS Journal.